​
​

Nurix Therapeutics (NRIX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Nurix Therapeutics Revenue Highlights

Latest Revenue (Y)

$76.99M

Latest Revenue (Q)

$12.59M

Main Segment (Y)

Collaboration Revenue

Nurix Therapeutics Revenue by Period

Nurix Therapeutics Revenue by Year

DateRevenueChange
2023-11-30-99.31%
2022-11-30-29.84%
2021-11-30-66.95%
2020-11-30--42.73%
2019-11-30--16.91%
2018-11-30--

Nurix Therapeutics generated $76.99M in revenue during NA 2023, up 99.31% compared to the previous quarter, and up 205.58% compared to the same period a year ago.

Nurix Therapeutics Revenue by Quarter

DateRevenueChange
2024-08-31-4.10%
2024-05-31--27.09%
2024-02-29-9.41%
2023-11-30--17.91%
2023-08-31--39.80%
2023-05-31-141.83%
2023-02-28-87.01%
2022-11-30--37.14%
2022-08-31--5.61%
2022-05-31-18.82%
2022-02-28-30.08%
2021-11-30--27.86%
2021-08-31-44.58%
2021-05-31-41.51%
2021-02-28--25.09%
2020-11-30-63.75%
2020-08-31--2.32%
2020-05-31-46.02%
2020-02-29-53.81%
2019-11-30--82.40%
2019-08-31-12.09%
2019-05-31-2.22%
2019-02-28--

Nurix Therapeutics generated $12.59M in revenue during Q3 2024, up 4.10% compared to the previous quarter, and up 41.04% compared to the same period a year ago.

Nurix Therapeutics Revenue Breakdown

Nurix Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceNov 23
Collaboration Revenue-
License Revenue-

Nurix Therapeutics's latest annual revenue breakdown by segment (product or service), as of Nov 23: Collaboration Revenue (74.02%), and License Revenue (25.98%).

Quarterly Revenue by Product

Product/ServiceAug 24May 24Nov 23Aug 23May 23
License Revenue-----
Collaboration Revenue-----

Nurix Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Aug 24: Collaboration Revenue (100.00%).

Nurix Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KYMRKymera Therapeutics--
ARVNArvinas--
NRIXNurix Therapeutics--
FHTXFoghorn Therapeutics--
RLAYRelay Therapeutics--
STOKStoke Therapeutics--
GBIOGeneration Bio--
STTKShattuck Labs--
PLRXPliant Therapeutics--
LYELLyell Immunopharma--
BDTXBlack Diamond Therapeutics--
CCCCC4 Therapeutics--
NKTXNkarta--
ELYMEliem Therapeutics--
PRLDPrelude Therapeutics--
SANASana Bio--
GLUEMonte Rosa Therapeutics--

NRIX Revenue FAQ

What is Nurix Therapeutics’s yearly revenue?

Nurix Therapeutics's yearly revenue for 2023 was $76.99M, representing an increase of 99.31% compared to 2022. The company's yearly revenue for 2022 was $38.63M, representing an increase of 29.84% compared to 2021. NRIX's yearly revenue for 2021 was $29.75M, representing an increase of 66.95% compared to 2020.

What is Nurix Therapeutics’s quarterly revenue?

Nurix Therapeutics's quarterly revenue for Q3 2024 was $12.59M, a 4.10% increase from the previous quarter (Q2 2024), and a -31.84% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $12.09M, a -27.09% decrease from the previous quarter (Q1 2024), and a -60.58% decrease year-over-year (Q2 2023). NRIX's quarterly revenue for Q1 2024 was $16.58M, a 9.41% increase from the previous quarter (Q4 2023), and a 30.74% increase year-over-year (Q1 2023).

What is Nurix Therapeutics’s revenue growth rate?

Nurix Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 158.78%, and for the last 5 years (2019-2023) was 147.43%.

What are Nurix Therapeutics’s revenue streams?

Nurix Therapeutics's revenue streams in v 23 are Collaboration Revenue, and License Revenue. Collaboration Revenue generated $56.99M in revenue, accounting 74.02% of the company's total revenue License Revenue generated $20M in revenue, accounting 25.98% of the company's total revenue

What is Nurix Therapeutics’s main source of revenue?

For the fiscal year ending Nov 23, the largest source of revenue of Nurix Therapeutics was Collaboration Revenue. This segment made a revenue of $56.99M, representing 74.02% of the company's total revenue.